comparative effectiveness of semaglutide and tirzepatide vs bariatric surgery Semaglutide vs Tirzepatide: Head-to-Head for Single vs. Dual Agonist Pharmacotherapy

Patients should understand the difference between investigational compounds and approved therapies when considering treatment options.

Leana Wen explains what people should know about the medication.

Our expert protocol covers the math, supplies, and sterile techniques for reliable research.

Compared with SGLT-2 inhibitor use, GLP-1 receptor agonist use was not associated with an increased risk of pulmonary aspiration (pooled risk ratio 0.98, 95% CI 0.73 to 1.31), although it was associated with a higher risk for discontinuation of endoscopy (1.99, 1.56 to 2.53)

Prolonged GLP-1 activation for lasting appetite control

When appetite drops significantly, the body often faces several nutritional challenges